Category:emulsifiers
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Specific Gravity: | 0.98900 @ 25.00 °C.
|
Boiling Point: | 360.00 °C. @ 760.00 mm Hg (est)
|
Vapor Pressure: | 0.000004 mmHg @ 25.00 °C. (est) |
Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
logP (o/w): | 7.698 (est) |
Soluble in: |
| water, 7.518e-011 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
BOC Sciences |
For experimental / research use only. |
sorbitan sesquioleate
|
Chemical-navi - Nikkol |
NIKKOL SO-15MV
Odor: characteristic Use: W/O emulsifier; plant-derived |
Chemical-navi - Nikkol |
NIKKOL SO-15V
Odor: characteristic Use: W/O emulsifier; anti-rust; plant-derived |
Kao Corporation |
RHEODOL AO-15V
Odor: characteristic Use: Emulsifiers for pharmaceuticals and cosmetics, Additives for lubricants |
Lipo Chemicals |
Liposorb® SQO
Odor: characteristic Use: Liposorb® SQO is a water-in-oil emulsifier. Liposorb® SQO is primarily used in oil-in-water emulsions in combination with a high HLB emulsifier such as Lipomulse® 165. The pair of emulsifiers produces fine-textured lotions and creams for skin care, sun care and color cosmetics. |
Lonza Group |
Lonzest™ SOC
|
Mohini Organics |
MONEMUL® - 83
Odor: characteristic Use: Monemul® - 83 is Non-ionic, Lipophillic (Hydrophobic, Oil Loving) surfactant. Used for preparing water in oil emulsifiers with a high degree of absorbency, good resistance to temperature fluctuations, Opacifiers for hydro carbon free ointment, Auxiliary emulsifiers for bees wax/borax and divalent soap systems such as calcium and magnesium Stearate, consumer household aerosols and an oil in water co-emulsifier for cosmetic, industrial oil and textile oils. |
Mohini Organics |
MONEMUL® - 83Hi
Odor: characteristic Use: MONEMUL® - 83Hi is Non-ionic, Lipophillic (Hydrophobic, Oil Loving) surfactant. The product made from 70% min Oleic acid carries the advantage of the performance of the product in the specialty applications. |
Mosselman |
Sorbitan Sesquioleate
|
Santa Cruz Biotechnology |
For experimental / research use only. |
Sorbitan sesquioleate
|
Sigma-Aldrich: Sigma |
For experimental / research use only. |
Sorbitan sesquioleate
|
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
Not determined
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | emulsifiers |
Recommendation for sorbitan sesquioleate (2:3) usage levels up to: | | not for fragrance use.
|
|
Recommendation for sorbitan sesquioleate (2:3) flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| anhydrohexitol sesquioleate (2:3) | | anhydrosorbitol sesquioleate (2:3) | | arlacel 83 | | arlacel C | | crill 43 | | emasol 41S | | emsorb 2502 | | emulgator 8972 | | glycomul SOC | (2R,3R,4R,5S)- | hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid | | hodag SSO | | liposorb SQ0 | | liposorb sqo | | lonzest SOC | | monemul - 83 | | montane 83 | | nikkol SO 15 | | nikkol SO-15MV | | nikkol SO-15V | | nissan nonion OP 83 | | nissan nonion OP 83RAT | | protachem SOC | | qo-33-f | | rheodol AO-15V | | sorbirol sq | | sorbitan (Z)-9-octadecenoate (2:3) | | sorbitan, (9Z)-9-octadecenoate (2:3) | | sorbitan, (Z)-9-octadecenoate (2:3) | | sorbitan, esters, sesqui-9-octadecenoate, (Z)-, (2:3) | | sorbitanum sesquioleylatum (2:3) | | sorgen 30 |
Articles:
PubMed:Reactivity to sorbitan sesquioleate affects reactivity to fragrance mix I. |
PubMed:Allergic contact dermatitis caused by sorbitan sesquioleate imitating severe glove dermatitis in a patient with filaggrin mutation. |
PubMed:Poly(ester amide) blend microspheres for oral insulin delivery. |
PubMed:Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir. |
PubMed:Contact allergy to sorbitans: a follow-up study. |
PubMed:Allergens in the American Contact Dermatitis Society Core Series. |
PubMed:The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles. |
PubMed:Drug distribution in enteric microparticles. |
PubMed:Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. |
PubMed:Polyvalent type IV sensitizations to multiple fragrances and a skin protection cream in a metal worker. |
PubMed:Sorbitan sesquioleate: an emerging contact allergen. |
PubMed:Sorbitan sesquioleate, a common emulsifier in topical corticosteroids, is an important contact allergen. |
PubMed:Preparation of polyurea capsules using electrocapillary emulsification. |
PubMed:Sorbitan sesquioleate. |
PubMed:Contact dermatitis. |
PubMed:Allergens in corticosteroid vehicles. |
PubMed:Allergic contact dermatitis to sorbitan sesquioleate in children. |
PubMed:Allergic contact dermatitis to sorbitan sesquioleate in Adaptic wound dressing. |
PubMed:The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion II: stable gastrointestinal absorption of a poorly water soluble new compound, ER-1258 in bile-fistula rats. |
PubMed:Preparation and in vitro evaluation of primaquine-conjugated gum arabic microspheres. |
PubMed:Preparation of Y2O3 nanoparticulate thin films using an emulsion liquid membrane system. |
PubMed:Final report on the safety assessment of sorbitan caprylate, sorbitan cocoate, sorbitan diisostearate, sorbitan dioleate, sorbitan distearate, sorbitan isostearate, sorbitan olivate, sorbitan sesquiisostearate, sorbitan sesquistearate, and sorbitan triisostearate. |
PubMed:Sorbitan sesquioleate as an allergen. |
PubMed:Relationship between antigen release and antibody response of infectious coryza water-in-oil-in-water emulsion vaccines. |
PubMed:Relation between antigen release and immune response of oil adjuvanted vaccines in chickens. |
PubMed:Preparation of CM-chitin microspheres by complexation with iron(III) in w/o emulsion and their biodisposition characteristics in mice. |
PubMed:Studies on microencapsulation of 5-fluorouracil with poly(ortho ester) polymers. |
PubMed:Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods. |
PubMed:Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. |
PubMed:Contact dermatitis due to emulsifiers. |
PubMed:Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. |
PubMed:Contact urticaria syndrome from sorbitan sesquioleate in a corticosteroid ointment. |
PubMed:Testing with fragrance mix. Is the addition of sorbitan sesquioleate to the constituents useful? |
PubMed:Contact urticaria syndrome from sorbitan sesquioleate in a corticosteroid ointment. |
PubMed:High sensitization rate to emulsifiers in patients with chronic leg ulcers. |
PubMed:Sorbitan sesquioleate--a potential allergen in leg ulcer patients. |
PubMed:A case of "contact allergy to corticosteroid.". |
PubMed:Patch testing with fragrance-mix and its constituents: discrepancies are largely due to the presence or absence of sorbitan sesquioleate. |
PubMed:Prevalence and sources of sensitization to emulsifiers: a clinical study. |
PubMed:Effects of sorbitan sesquioleate on non-immunologic immediate contact reactions to benzoic acid. |
PubMed:Skin contact allergy to emulsifiers. |
PubMed:Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. |
PubMed:Contact sensitivity to emulsifiers. |
|